Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $23.7 million.

  • Rockwell Medical's Cash & Current Investments rose 2974.5% to $23.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.7 million, marking a year-over-year increase of 2974.5%. This contributed to the annual value of $21.6 million for FY2024, which is 9754.92% up from last year.
  • Rockwell Medical's Cash & Current Investments amounted to $23.7 million in Q3 2025, which was up 2974.5% from $18.4 million recorded in Q2 2025.
  • Rockwell Medical's Cash & Current Investments' 5-year high stood at $46.1 million during Q1 2021, with a 5-year trough of $8.6 million in Q1 2024.
  • In the last 5 years, Rockwell Medical's Cash & Current Investments had a median value of $18.4 million in 2025 and averaged $21.4 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first plummeted by 7851.28% in 2022, then skyrocketed by 10107.9% in 2025.
  • Rockwell Medical's Cash & Current Investments (Quarter) stood at $22.4 million in 2021, then fell by 4.22% to $21.5 million in 2022, then plummeted by 49.12% to $10.9 million in 2023, then skyrocketed by 97.55% to $21.6 million in 2024, then grew by 9.74% to $23.7 million in 2025.
  • Its Cash & Current Investments stands at $23.7 million for Q3 2025, versus $18.4 million for Q2 2025 and $17.3 million for Q1 2025.